Affluent Medical SA (FR:AFME) has released an update.
Affluent Medical has issued a new prospectus for 6,190,831 shares at 1.38 euros each in a capital increase, excluding existing shareholders’ preemptive rights, raising a total of 8.54 million euros. This move has allowed Edwards Lifesciences to acquire a 9.21% stake in the company. The capital increase dilutes existing shareholders’ stakes, with a 1% stake being reduced to 0.84% post-transaction.
For further insights into FR:AFME stock, check out TipRanks’ Stock Analysis page.
